BUEE; Luc

Patent Applications and Registrations

Patent applications and USPTO patent grants for BUEE; Luc.The latest application filed is for "treatment of taupathy disorders by targeting new tau species".

Company Profile

5.7.11

BUEE; Luc - Lille Cedex FR
Buee; Luc - Lille FR
Buee; Luc - Templemars FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Taupathy Disorders By Targeting New Tau Species App 20220177558 - HAMDANE; Malika ; et al.	2022-06-09
New Anti Tau Svqivykpv Epitope Single Domain Antibody App 20220017611 - BUEE; Luc ; et al.	2022-01-20
Novel 1,4-bis(3-aminopropyl)piperazine Derivative And Its Use App 20200407325 - SERGEANT; Nicolas ; et al.	2020-12-31
1,4-bis(3-aminopropyl)piperazine derivative and its use Grant 10,807,958 - Sergeant , et al. October 20, 2	2020-10-20
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imid- azol-2-amine, preparation thereof and use of the same Grant 10,772,884 - Burlet , et al. Sept	2020-09-15
New Tau Species App 20200031891 - BUEE; Luc ; et al.	2020-01-30
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imid- azol-2-amine, preparation thereof and use of the same Grant 10,537,569 - Burlet , et al. Ja	2020-01-21
SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMID- AZOL-2-AMINE, PREPARATION THEREOF A App 20190381036 - BURLET; Stephane ; et al.	2019-12-19
Novel 1,4-bis(3-aminopropyl)piperazine Derivative And Its Use App 20180290981 - SERGEANT; Nicolas ; et al.	2018-10-11
Novel 1,4-bis(3-aminopropyl)piperazine Derivative And Its Use App 20180072679 - SERGEANT; Nicolas ; et al.	2018-03-15
SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMID- AZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME App 20170151235 - BURLET; Stephane ; et al.	2017-06-01
Sulphate salts of N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imid- azol-2-amine, preparation thereof and use of the same Grant 9,562,018 - Burlet , et al. February 7, 2	2017-02-07
SULPHATE SALTS OF N-(3-(4-(3-(DIISOBUTYLAMINO)PROPYL)PIPERAZIN-1-YL)PROPYL)-1H-BENZO[d]IMID- AZOL-2-AMINE, PREPARATION THEREOF AND USE OF THE SAME App 20160108003 - BURLET; Stephane ; et al.	2016-04-21
Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases Grant 9,044,478 - Sergeant , et al. June 2, 2	2015-06-02
Antibodies specific of the .beta.-amyloid peptides and their uses as diagnostic agents or drugs Grant 8,343,493 - VanMechelen , et al. January 1, 2	2013-01-01
Antibodies Specific Of The Beta-amyloid Peptides And Their Uses As Diagnostic Agents Or Drugs App 20110059092 - Vanmechelen; Eugeen ; et al.	2011-03-10
Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases App 20090149464 - Sergeant; Nicolas ; et al.	2009-06-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.